- SweDeliver's summer internships valuable for all parties 2021-10-19
- Mentoring program with restrictions and new dimensions 2021-10-19
- Meet our partners: Clinical Trial Consultants 2021-10-18
- Bertil Abrahamsson is new chair of SweDeliver 2021-10-18
- SciLifeLab leads new national investment in oligonucleotides 2021-10-18
Seminars & Events
Prof. Olivia Merkel (DE)
4 November at 12.15–13.00
Drugging the undruggable with nucleic acid therapeutics
Meet our partners
Clinical Trial Consultants
Swedish full-service CRO with clinical conduct in focus
Breaking new ground towards more efficient development of oral drugs
New chair of SweDeliver
"SweDeliver's development is very positive in many ways"
This is SweDeliver
SweDeliver is a world leading research and competence centre in Drug Delivery. Many novel molecules in the drug discovery and development pipeline are biological compounds such as proteins, peptides and RNA. These display problems of poor solubility, membrane permeability and low bioavailability. Thus, the Drug Delivery area is today facing tremendous challenges to develop new drug therapies.
SweDeliver was established in response to these challenges. SweDeliver is based on a multi-disciplinary collaboration between academia and industry with financial support from Vinnova (Sweden’s Innovation Agency). The Faculty of Pharmacy at Uppsala University is the academic hub of the Centre whereas our 15 industrial partners contribute with expertise and research infrastructure as well as industrial perspectives and needs within each of the three main research areas of the Centre.
SweDeliver has prioritized to focus on outstanding research challenges within
- Parenteral Drug Delivery
- Oral Drug Delivery
- Pulmonary Drug Delivery
The research will ultimately lead to development of new and improved drug therapies with respect to both efficacy and patient safety. The Centre will also further support the strong research environment and the drug delivery ecosystem in the Nordic region.